Imugene Ltd IMU.ASX

‎A$‎0.1450.01(7.41%)(1D)

• Delayed prices by CBOE AUS • in AUD

Invest in Imugene Ltd
Today

Create an eToro account to buy IMU.ASX stock on a secure, user-friendly, multi-asset trading platform.

Imugene Ltd IMU.ASX

Buy IMU.ASX

Trending stocks

See stocks with the biggest daily volume spikes vs. their 3-month average.

CNTA

Centessa Pharmaceuticals plc

‎$‎39.64

-0.20%

APLS

Apellis Pharmaceuticals Inc.

Exela Technologies Pref

‎$‎0

+1,500.00%

ELPC

Companhia Paranaense de Energia - COPEL

MAX

*Past performance is not an indication of future results

Jump to:

About IMU.ASX >
How to Buy? >
Top Guides >

The Imugene Ltd share price is stable this week.

The Imugene Ltd share price today is ‎A$‎0.145, reflecting a ‎7.41‎% change over the last 24 hours and ‎0‎% over the past week. The current market capitalization of IMU.ASX is ‎A$‎51.77M with an average volume in the last three months of 1.66M. The stock has a P/E ratio of -0.65 and a dividend yield of 0%. With the stock’s beta sitting at 0.26

Why invest in stocks on eToro?

Start with ‎$‎50

Low fees

users worldwide

Across 70+ countries

Get Started

IMU.ASX Key Metrics

Market Cap

‎A$‎51.77M

Day’s Range

‎A$‎0.135 - ‎A$‎0.145

52W Range

‎A$‎0.125 - ‎A$‎1.802

Average Volume (3M)

1.66M

Price-Earnings Ratio

-0.65

Revenue

‎A$‎0

Dividend (Yield)

‎A$‎0 (0%)

Prev Close

‎A$‎0.145

EPS

‎A$‎-0.22

Beta

0.26

How can I buy Imugene Ltd stocks?

To purchase Imugene Ltd:

Create an eToro account:

Deposit funds:

Deposit funds into your eToro account using your preferred payment method.

Search and purchase:

Search the Imugene Ltd (IMU.ASX) page and place an order to buy Imugene Ltd.

Buy IMU.ASX

Looking for more information? Check out our guide on Academy.

What Is Imugene Ltd?

Imugene Limited is a global clinical-stage immune-oncology organisation which designs cancer treatments that use the patient’s immune system to treat tumours. Based in Australia, the company has several clinical trials in progress.

Imugene Limited can be found under the Health Technology sector on the eToro platform. Last fiscal year, the company’s revenue was 2.41m AUD, with an annual growth rate of -9.96%.

Explore the IMU.ASX price chart and monitor its ongoing performance by adding it to your virtual portfolio on eToro.

CEO

Leslie Chong

Employees

Founded

1986

Sydney, New South Wales (NSW), AU

Med Tech

Sydney

Get Started

Top Guides

Our top picks for the most relevant guides from the eToro Academy

Top Dividend Stocks for 2026

Gear up for 2026 with top dividend stocks. Explore the potential of J&J, Chevron, Coca Cola, Verizon, Caterpillar, McDonald’s with eToro’s expert analysts.

Stock Trading And Investing For Beginners

Learn stock trading basics with our beginner's guide. Discover how to choose stocks, manage risks, and build your first investment portfolio.

AI Stocks Poised for Growth in 2026

Gear up for 2026 with AI stocks. Dive into the potential of Nvidia, Broadcom, CrowdStrike, Arista Networks, and Amphenol, through eToro’s expert analysis.

Go to the Academy >

Invest in Imugene Ltd
Today

Create an eToro account to buy IMU.ASX stock on a secure, user-friendly, multi-asset trading platform.

Get Started

FAQ

What is the current price of Imugene Ltd stock?

The current price of IMU.ASX is ‎A$‎0.145.

What are analysts’ forecasts for Imugene Ltd?

Analysts offer forecasts for Imugene Ltd based on market trends, financial reports and projected growth. Check the latest forecast for future price movements.

What is the market cap of Imugene Ltd?

The market capitalisation of Imugene Ltd is ‎A$‎51.77M

Daily Movers

Explore the biggest stocks movers on the market.